Affiliation:
1. Women's Hospital, School of Medicine, Zhejiang University
Abstract
Abstract
Background
The levonorgestrel-releasing intrauterine system (LNG-IUS) is an efficient contraceptive and nonsurgical treatment for gynecological conditions. However, its expulsion rates are concerning. In this study, we suggest the use of non-absorbable suture fixation through hysteroscopy to mitigate expulsions and evaluate the safety and outcomes of this procedure.
Methods
This study included 73 women (average age: 41.34 years) with a history of LNG-IUS expulsion who underwent hysteroscopic suture fixation of the LNG-IUS at Women’s Hospital, Zhejiang University School of Medicine, between August 2022 and August 2023. Postoperative assessment was conducted using electronic questionnaires at 1, 3, and 7 days, along with outpatient follow-ups and ultrasonography at 1, 3, 6, and 12 months.
Results
The day surgery team successfully performed 73 procedures with a mean duration of 37.81 ± 15.42 min, encountering no complications. Follow-up was conducted for an average of 183.56 days for all 73 patients. Among them, 70 underwent postoperative imaging examinations, primarily ultrasonography, with an average follow-up imaging time of 117.33 days. This study revealed low expulsion (4.29%) and downward-shift (7.14%) rates. The primary adverse reactions observed were irregular bleeding or spotting in 71.23% of cases and an increased vaginal discharge rate of 8.22%.
Conclusion
Hysteroscopic LNG-IUS suture fixation is safe and effective for reducing expulsion rates in women with a history of expulsion. However, this procedure is associated with higher rates of irregular postoperative bleeding and increased vaginal discharge.
Publisher
Research Square Platform LLC
Reference25 articles.
1. Current and Future Medical Therapies for Adenomyosis;Cope AG;Semin Reprod Med,2020
2. ESHRE guideline: endometriosis;Becker CM;Hum Reprod Open,2022
3. Management of endometrial hyperplasia;Royal College of Obstetricians andGynaecologists;Green-top guideline No 67 RCOG/BSGE joint guideline,2016
4. Progestogen-releasing intrauterine systems for heavy menstrual bleeding;Bofill Rodriguez M;Cochrane Database Syst Rev,2020
5. Prevention of Benign Endometrial Polyp Recurrence Using a Levonorgestrel-releasing Intrauterine System in Premenopausal Patients: A Retrospective Cohort Study;Wang Y;J Minim Invasive Gynecol,2020